Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.58
Bid: 18.40
Ask: 18.60
Change: -0.27 (-1.43%)
Spread: 0.20 (1.087%)
Open: 18.48
High: 18.58
Low: 18.40
Prev. Close: 18.85
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Glass Lewis recommends to support Nanoco’s Board

7 Aug 2023 07:00

RNS Number : 4301I
Nanoco Group PLC
07 August 2023
 

For Immediate Release 7 August 2023

 

NANOCO GROUP PLC

("Nanoco", the "Company" or the "Group")

 

Glass Lewis recommendation to support Nanoco's Board

 

General Meeting - 10 August proxy voting deadline

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, notes the voting recommendations recently published by Glass Lewis & Co. ("Glass Lewis") in relation to the Group's forthcoming General Meeting to be held on 14 August 2023.

The Glass Lewis report recommends that investors vote AGAINST all resolutions that have been proposed, as follows.

· vote AGAINST all the resolutions to remove the current Board of Nanoco

· vote AGAINST the proposed appointment of all the Requisitionists' director nominees

This is in addition to the report issued by Institutional Shareholder Services ("ISS"), as announced on 2 August 2023, which recommended that investors:

· vote AGAINST all the resolutions to remove the current Board of Nanoco

· vote AGAINST the proposed appointment of the following director nominees:

Tariq Hamoodi

Greg Moeller

Dooyong Lee

Benjamin Barnett

Ikchoon Tim Kang

 

General Meeting on 14 August 2023

The Board is firmly of the view that the changes proposed by Mr Hamoodi are not in the best interests of the Company or its shareholders for the following reasons:

Nanoco is at an exciting inflection point, with the Samsung litigation proceeds fully underpinning our transition from an R&D first mover to a leading producer of next-generation QD materials in the short term

The Requisitionists continue to fail to present a clear, coherent and credible strategy

Delivering shareholder value needs an experienced and qualified board - none of the Requisitionists' nominee directors have ever served on the Board of a UK public company

The Board changes proposed by the Requisitionists in effect would represent a total change of control of Nanoco with no takeover premium being paid - a backdoor takeover attempt

The Requisitionists' proposals will destroy the significant potential value in Nanoco's organic business, risk turning the Company into a highly speculative litigation shell, and will result in an exodus of key talent from the business, including Dr Nigel Pickett, the Group's co-founder and Chief Technology Officer

Mr Hamoodi's unfounded allegations create a false narrative that misleads Nanoco shareholders

Shareholders have a lot to lose - the Requisitionists' resolutions are not in the best interests of shareholders

Proxy voting deadline of 10 August 2023 (11:00 BST)

The Board strongly encourages all Shareholders, regardless of whether or not they intend to attend the General Meeting in person, to submit their votes via proxy as early as possible.

All proxy appointments should be received by no later than 11:00 a.m. on 10 August 2023. CREST members are advised to vote electronically through the CREST electronic proxy appointment service.

Shareholders are reminded that if their shares are registered in the name of a nominee, they must liaise with their nominee to ensure their proxies are validly submitted by the above deadline. If in any doubt about your shareholding, please contact our registrar, Neville Registrars Limited, Neville House, Steelpark Road, Halesowen B62 8HD on telephone number 0121 585 1131, or by e-mail on info@nevilleregistrars.co.uk.

The form of proxy can be found on Nanoco's Investor Relations website here: https://www.nanocotechnologies.com/investors/documents/

Instructions on how to fill out and submit the form of proxy can be found on page seven of the Circular and Notice of General Meeting here: https://wp-nanoco-2020.s3.eu-west-2.amazonaws.com/media/2023/07/Nanoco-Circular-and-Notice-of-General-Meeting.pdf

For Shareholders who hold their shares via nominee accounts, instructions on how to instruct your nominee to vote can be found on page eight of the Circular and Notice of General Meeting.

- Ends -

For further information, please contact:

Nanoco Group PLC:

Brian Tenner, CEO +44 (0) 1928 761 422

Liam Gray, CFO & Company Secretary

 

Peel Hunt (Joint Corporate Broker):

Paul Gillam +44 (0) 20 7418 8900

Richard Chambers

James Smith

 

Turner Pope Investments (Joint Corporate Broker):

Andrew Thacker +44 (0) 20 3657 0050

James Pope

 

MHP:

Reg Hoare / Matthew Taylor +44 (0) 20 3128 8793

nanoco@mhpgroup.com

 

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots and other nano-materials. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display, Sensor and Electronics markets. An interesting property of quantum dots is their absorption spectrum. Nanoco's HEATWAVE™ quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectrum, rendering them useful for applications including image sensors. Another interesting property of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSATEIRIIV
Date   Source Headline
16th Jul 20214:41 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSNon-dilutive loan note subscription
5th Jul 20217:30 amRNSDevelopment Agreement
28th Jun 20217:00 amRNSLitigation update and non-dilutive debt facility
10th Jun 202111:33 amRNSBlocklisting Six-Monthly Return
24th May 202112:20 pmRNSHolding(s) in Company
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.